Zobrazeno 1 - 9
of 9
pro vyhledávání: '"M Sáez Garrido"'
Autor:
H Alabort Ayllón, J Marco del Rio, J. M. Collado Sanz, JL Sánchez Serrano, M Sáez Garrido, B Serna Serrano, C Del Pozo Carlavilla, S Ruiz Sánchez, E Tebar Martínez, C García Gómez
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Baricitinib is an immunosuppressive agent included as one of the therapeutic options for COVID-19 in the Spanish protocol Agencia Espanola del Medicamento y Productos Sanitarios. Aim and objectives The objective was to asses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e16f9f0c613d342530e8a44dc42c937
https://doi.org/10.1136/ejhpharm-2021-eahpconf.145
https://doi.org/10.1136/ejhpharm-2021-eahpconf.145
Autor:
S Plata Paniagua, E Tebar Martínez, H Alabort Ayllón, M Del Pozo Carlavilla, M Sáez Garrido, M Clemente Andújar, S Ruiz Sánchez, J. M. Collado Sanz, B Serna Serrano, C Del Pozo Carlavilla
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Tocilizumab (TCZ) is an immunosuppressor drug, IL-6 inhibitor, indicated for the treatment of rheumatoid arthritis and cytokine release syndrome associated with CAR T cell therapy. It was proposed as a compassionate treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15d9c182bbf7d34331eea0fbca09ac21
https://doi.org/10.1136/ejhpharm-2021-eahpconf.164
https://doi.org/10.1136/ejhpharm-2021-eahpconf.164
Autor:
E González Lozano, M Díaz Ramón, Já Cano Molina, M Sáez Garrido, A Ruiz Gómez, O García Molina, A Laorden Carrasco, F Golnabi Dowlatshahi
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance The use of proton pump inhibitors (PPIs) has increased considerably in recent years, probably due to their prescription in unjustified clinical situations or their prolonged maintenance without prescription revision, which c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90b4802f00172f29de9ed717a9bd7c69
https://doi.org/10.1136/ejhpharm-2021-eahpconf.239
https://doi.org/10.1136/ejhpharm-2021-eahpconf.239
Autor:
M Clemente Andújar, B Serna Serrano, S Ruiz Sánchez, H Alabort Ayllón, C Del Pozo Carlavilla, M Sáez Garrido, S Plata Paniagua, E Tebar Martínez, M Del Pozo Carlavilla, CS Juan Manuel
Publikováno v:
Section 4: Clinical pharmacy services.
Background and importance Tocilizumab (TCZ) is an immunosuppressor drug, IL-6 inhibitor, indicated for the treatment of rheumatoid arthritis and cytokine release syndrome associated with CAR T cell therapy It was proposed as a compassionate treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77f7a4e587592c9385f96ae1d60b440a
https://doi.org/10.1136/ejhpharm-2021-eahpconf.163
https://doi.org/10.1136/ejhpharm-2021-eahpconf.163
Autor:
M Díaz Ramón, A. Espuny Miró, A Ruiz Gómez, L Menéndez Naranjo, A Laorden Carrasco, Já Cano Molina, M Sáez Garrido
Publikováno v:
Section 5: Patient Safety and Quality assurance.
Background and importance Over the last few years there have been remarkable advances in chronic hepatitis C virus (HCV) drug development, and the goals of most new regimens have been increasing sustained viral response rates (SVR), improving tolerab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f837cc8d3e1211371e44916e6fa2e57c
https://doi.org/10.1136/ejhpharm-2020-eahpconf.350
https://doi.org/10.1136/ejhpharm-2020-eahpconf.350
Publikováno v:
Section 5: Patient Safety and Quality Assurance.
Background Medication errors lead to higher morbidity, mortality and expenditure. The likelihood of mistakes is higher in the Emergency Department (ED). Purpose To determine the incidence, the type of discrepancies and reconciliation errors (RE) upon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23910db32873868f05327900f52301ff
https://doi.org/10.1136/ejhpharm-2019-eahpconf.596
https://doi.org/10.1136/ejhpharm-2019-eahpconf.596
Autor:
GS Juana Inés, GL Eduardo, FA Juan José, RG Agustina, M Sáez-Garrido, DN Amelia, TL Aina, VS Sergio
Publikováno v:
Eur J Hosp Pharm
Background Treatment with Lutetium177 is having a highly efficient therapeutic approach for the systemic treatment of various types of cancer including neuroendocrine tumours. However, renal and haematopoietic toxicities are the major limitations of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cf733f5960148f524d38004e8fdab50
https://europepmc.org/articles/PMC7535177/
https://europepmc.org/articles/PMC7535177/
Autor:
A Ruiz Gómez, APareja Rodriguez de Vera, M Almanchel Rivadeneyra, M Sáez Garrido, A Tomás Luiz
Publikováno v:
Eur J Hosp Pharm
Background An interdisciplinary working group developed a standardised perioperative antibiotic prophylaxis (AP) protocol. In 2014, in the first post-intervention evaluation, we observed that 26.8% of the surgeries’ non-compliance with the protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e29daa2602ccacd9f6abca48286726a2
https://doi.org/10.1136/ejhpharm-2018-eahpconf.166
https://doi.org/10.1136/ejhpharm-2018-eahpconf.166
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.